Analysis Of Clinical Sample Services | BIOalternatives | Utilizing our integrated services for pharmacology, our laboratory proposes to analyze your own biological samples from clinical trials. | |
Assay Development Services | BIOalternatives | BIOalternatives was founded fifteen years ago to offer a personalized approach for R&D in biology. This remains our core business and our highly trained scientists use cutting-edge technologies to provide you the best solution to outsource your projects, ...weiterlesen BIOalternatives was founded fifteen years ago to offer a personalized approach for R&D in biology. This remains our core business and our highly trained scientists use cutting-edge technologies to provide you the best solution to outsource your projects, avoiding the heavy and time consuming R&D phases. verkürzen | |
High Content Screening Services | BIOalternatives | High Content Screening (HCS) is a powerful approach for a fast compound selection from your libraries (chemical entities, crude extracts, actives, etc) focusing on a specific biological activity or target in cell cultures (primary cells, cell lines, co-cu...weiterlesen High Content Screening (HCS) is a powerful approach for a fast compound selection from your libraries (chemical entities, crude extracts, actives, etc) focusing on a specific biological activity or target in cell cultures (primary cells, cell lines, co-cultures). verkürzen | |
Histology & IHC Services | BIOalternatives | The BIOalternatives laboratory will analyze your own cell or tissue samples. | |
Molecular Biology Services | BIOalternatives | Additionally to our integrated services for pharmacology, our laboratory analyzes your own biological samples using efficient and fully recognized molecular biology methods. | |
Safety / Toxicology Services | BIOalternatives | Safety assessment of compounds is an important criterion before expensive preclinical and clinical studies. In order to predict early cytotoxicity or specific cellular impacts, BIOalternatives provides services for toxicity and safety profiling in a wide ...weiterlesen Safety assessment of compounds is an important criterion before expensive preclinical and clinical studies. In order to predict early cytotoxicity or specific cellular impacts, BIOalternatives provides services for toxicity and safety profiling in a wide range of normal cells or cell lines (blood and immune cells, neurons, epithelial and mesenchymal cells). verkürzen |